THE WHAT? Men’s health brand Numan has raised US$40 million in a Series B funding round, led by White Star Capital.
THE DETAILS Other participants included existing investors Novator, VNV Global, Anthemis Exponential, Colle Capital and new investor Hanwha Group.
Numan covers erectile dysfunction (ED), premature ejaculation, hair loss, gut and lung health and nutritional deficiencies, with the pandemic said to have expanded the need to address health concerns remotely.
THE WHY? Said to be a ‘significant milestone’ in the company’s journey to help men be healthier, the funding will be used for company expansion.
Taking to a statement, Sokratis Papafloratos, CEO and founder of Numan, said: “This funding is a significant milestone on our journey to help millions of men be healthier. White Star Capital is one of the best investors in our space, and I’m delighted to be working together along with a wider team of brilliant investors.”